Abstract: Methods and devices provide a wireless communications hub device and services enabling remote access to electronic medical or fitness devices in a manner that simplifies device networking. A wireless communication hub device may include a processor and wireless communication transceivers configured to connect to cellular and/or WiFi networks to access a remote server, and wired and/or wireless local networks for connecting to electronic medical or fitness devices. The wireless communication hub device may plug into a power source, connect to an electronic medical or fitness device, and communicate via a second wireless network with an associated server-based service. The system enables discovery of the wireless communication hub device and connected electronic medical or fitness devices.

Abstract: Certain implementations of the disclosed technology may include methods and computing systems for performing high-density data compression, particularly on numerical data that demonstrates various patterns, and patterns of patters. According to an example implementation, a method is provided. The method may include extracting a data sample from a data set, compressing the data sample using a first compression filter configuration, and calculating a compression ratio associated with the first compression filter configuration. The method may also include compressing the data sample using a second compression filter configuration and calculating a compression ratio associated with the second compression filter configuration.

Abstract: A method and system is provided for provisioning curated insurance service. The present application provides a method and system for provisioning curated insurance service, comprises receiving consumer data along with geo-spatial data about insurance products; provisioning through a platform (102), plurality of insurance products to the consumer based on the consumer data; receiving from the consumer, one or more criteria for the insurance product selection; and provisioning quotation for a single or group insurance product to the consumer based on the one or more criteria through the platform (102).

Abstract: Methods and devices provide a wireless communications hub device and services enabling remote access to electronic medical or fitness devices in a manner that simplifies device networking. A wireless communication hub device may include a processor and wireless communication transceivers configured to connect to cellular and/or WiFi networks to access a remote server, and wired and/or wireless local networks for connecting to electronic medical or fitness devices. The wireless communication hub device may plug into a power source, connect to an electronic medical or fitness device, and communicate via a second wireless network with an associated server-based service. The system enables discovery of the wireless communication hub device and connected electronic medical or fitness devices.

Abstract: Method 100 and device for quantifying heart rate variability coherence of a subject is disclosed herein. The method 100 comprises obtaining a bio-signal (such as a PPG signal) from the subject at 102 and deriving a time-domain heart rate variability signal from the bio-signal at 108. Further, at 112, the method 100 further includes correlating the time-domain heart rate variability signal with a sine wave representing a time domain reference heart rate variability signal to obtain a correlated heart rate variability signal, and this includes adjusting frequency of the sine wave and performing cross-correlation between the sine wave at each of the adjusted frequencies and the heart rate variability signal to obtain the correlated heart rate variability signal. Further, at 116, the method includes quantifying the heart rate variability coherence based on the correlated heart rate variability signal.

Abstract: The present invention relates to an improved method for the manufacture of Isradipine, 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester. Which, involves reacting 2,1,3-benzoxadiazole-4-carboxaldehyde with methyl acetoacetate in the presence of acetic acid and piperidine in diisopropyl ether. To obtain the product 2-acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester which is then reacted with isopropyl-?-aminocrotonate in ethanol at 25 to 35° C. to obtain the product.

Abstract: The present invention relates to the process for the preparation of anhydrous Gabapentin of pharmaceutical grade from the Gabapentin acid addition salts. The process consists of neutralizing the said acid addition salts with an organic base in water to get an aqueous solution comprising of Gabapentin and amine acid addition salt dissolved in water. The process further comprises of a method to separate the Gabapentin and the amine acid addition salt from such an aqueous solution and to recover Gabapentin as an anhydrous Gabapentin form II.

Abstract: The present invention relates to an improved method for the manufacture of Isradipine, 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester. which, involves reacting 2,1,3-benzoxadiazole-4-carboxaldehyde with methyl acetoacetate in the presence of acetic acid and piperidine in diisopropyl ether. To obtain the product 2-acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester which is then reacted with isopropyl-?-aminocrotonate in ethanol at 25 to 35° C. to obtain the product.